GLP-1 receptor agonists, such as Ozempic and Wegovy, are linked to an increased risk of low blood pressure episodes, according to a study presented at the Endocrine Society’s annual meeting. Research from Northwestern University found that patients on these medications experienced higher rates of dizziness and fainting, particularly among those aged 65 and over and individuals with diabetes.
How do GLP-1 drugs affect blood pressure?
The Northwestern University study analyzed health data from 42,000 adults who were already prescribed at least two types of blood pressure medication. Researchers tracked these patients over six, 12, and 24-month intervals after they began taking GLP-1 drugs. The findings indicated that the rate of low blood pressure events rose from 8.7% to 10.2% within the first six months of treatment. These elevated risks persisted through the 12-month follow-up period, according to the official release from the university.
Secondary analysis from the Northwestern study suggests that weight loss alone did not explain the increased risk, suggesting other mechanisms of action may be at play.
Why are clinicians concerned about patient safety?
Dr. Micah Eimer, the study’s senior author, described the findings as “statistically significant” due to the potential severity of low blood pressure events. Eimer noted that low blood pressure events can lead to outcomes including hitting your head, crashing your car, or breaking a hip. He expressed particular concern regarding patients who access GLP-1 medications without direct and ongoing clinical supervision. Eimer recommends that healthcare providers develop specific strategies to monitor and mitigate these risks for their patients.
What are the primary risks for specific demographics?
The study highlights that certain patient groups face a higher likelihood of experiencing these adverse events. Adults aged 65 and older and patients living with diabetes were identified as the most at risk. While these results offer new insights into medication side effects, researchers emphasize that more research is needed to confirm the study’s findings.
Pro Tip: Managing Medication Risks
If you are taking GLP-1 medications, consult your doctor about your current blood pressure management plan. Ask about symptoms of hypotension, such as lightheadedness or fainting, and ensure you have a structured plan for regular monitoring.
Frequently Asked Questions
Do GLP-1 drugs cause low blood pressure?
According to the Northwestern University study, GLP-1 drugs are associated with an increased risk of low blood pressure episodes, such as dizziness and fainting, in patients already taking blood pressure medication.
Who is most at risk for these episodes?
The study identified adults aged 65 and older and individuals with diabetes as being the most at risk.
Does weight loss explain the risk?
No. A secondary analysis indicated that weight loss alone did not explain the increased risk, suggesting other mechanisms of action may be at play.
Are you currently managing your health while on GLP-1 medication? Share your questions or experiences with your healthcare provider to ensure your treatment plan remains safe and effective. For more updates on medical research and health policy, subscribe to our newsletter.
Worth a look